NASH Explored - Emerging Concepts in Nonalcoholic Steatohepatitis

Nov 12 2023

Product Theater 1, Exhibit Hall B - Hynes Convention Center

10:15 - 11:00 AM EST

Description

Supported by: Madrigal Pharmaceuticals

This session will explore several emerging concepts in NASH including: (1) epidemiology and comorbidities, (2) pathophysiology and the role of lipotoxicity in the liver, (3) morbidity and mortality, (4) patient identification and monitoring approaches, and (5) disease management strategies.

Presenters:

Stephen A. Harrison, M.D., COL (ret.)

Naim Alkhouri, MD, FAASLD